Off-label prescribing in palliative care: A survey of independent prescribers

Culshaw, Joseph; Kendall, David; Wilcock, Andrew
April 2013
Palliative Medicine;Apr2013, Vol. 27 Issue 4, p314
Academic Journal
The article discusses 'off-label' use of a drug beyond the specifications of its Marketing Authorization which is widespread in palliative care. Study aims to obtain a contemporary view of how medical and non-medical independent prescribers adhere to current regulatory guidance. It also discusses design of the study and results were analyzed using descriptive statistics. It was concluded that doctors appear better able to adhere to their regulatory body guidance.


Related Articles

  • The challenge of off-label prescribing. Phillips, Jane // International Journal of Palliative Nursing;2015, Vol. 21 Issue 9, p419 

    The author reflects on off-label prescribing of medicines in New Zealand, highlighting the survey of palliative care physicians in Australia and New Zealand. The study reportedly revealed that most physicians are not aware of policies requiring patient consent for off-label prescribing at their...

  • The impact of a pharmacist as a member of healthcare team on facilitating evidenced-based prescribing of innovative drugs in an Italian oncology department. Cioffi, Pasquale; Antonelli, Daniela; Belfiglio, Maurizio; Melena, Stefania; Petrelli, Fabio; Grappasonni, Iolanda // Journal of Oncology Pharmacy Practice;Jun2012, Vol. 18 Issue 2, p207 

    Aims and background: At the Oncology Department of the Chieti and Ortona Hospitals, the pharmacist designated by the Abruzzo Region to oversee the obligatory monitoring of innovative oncological drugs listed in the database of the Italian Medicines Agency (AIFA) collaborates with oncologists to...

  • An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide. Newton, Phillip J.; Davidson, Patricia M.; Sanderson, Christine // BMC Palliative Care;2012, Vol. 11 Issue 1, p6 

    Background: Off-label prescribing is common in palliative care. Despite inconsistent reports of the benefit of nebulised frusemide for breathlessness, its use continues to be reported. Methods: An online survey was emailed to 249 members of the Australian and New Zealand Society of Palliative...

  • The impact of legislation on drug substances used off-label in paediatric wards-a nationwide study. Haslund-Krog, Sissel; Mathiasen, René; Christensen, Hanne; Holst, Helle // European Journal of Clinical Pharmacology;Apr2014, Vol. 70 Issue 4, p445 

    Purpose: This nationwide study is aimed at describing to what extent the European Paediatric Regulation has met therapeutic needs in children. Methods: Data for each drug substance in defined daily doses (DDD) were extracted from the national Danish data base. We evaluated if drug substances...

  • Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors. To, Timothy Hm; Agar, Meera; Shelby-James, Tania; Abernethy, Amy P; Doogue, Matthew; Rowett, Debra; Ko, Danielle; Currow, David C // Palliative Medicine;Apr2013, Vol. 27 Issue 4, p320 

    The article discusses a study conducted to document off-label use policies (including disclosure and consent) in Australian palliative care units and current practices by palliative care clinicians. The study included survey asking clinicians their most frequent off-label medication/indication...

  • Prescribing in palliative care A quest for appropriateness. Toscani, Franco // Palliative Medicine;Apr2013, Vol. 27 Issue 4, p293 

    The author discusses prescription of correct and appropriate medication in palliative care. He also comments on distinguishing those prescriptions supported by evidence should be handled safely with caution. He also provides four reasons for the issue of palliative care off-label prescribing. He...

  • Strategy to address innovative off-label medication use in China: grading management. Hanbin Wu; Gao Wu // European Journal of Clinical Pharmacology;Oct2014, Vol. 70 Issue 10, p1271 

    A letter to the editor is presented which is concerned with the off label use of medications in China.

  • Recent Literature.  // Journal of Palliative Medicine;Sep2012, Vol. 15 Issue 9, p1048 

    No abstract available.

  • Clonidine Utilization Trends for Medicaid Children. Yoon, Esther Y.; Cohn, Lisa; Rocchini, Albert; Kershaw, David; Clark, Sarah J. // Clinical Pediatrics;Oct2012, Vol. 51 Issue 10, p950 

    Objective. To characterize clonidine utilization trends among children. Design/Methods. Serial cross-sectional analysis of Michigan Medicaid claims data for children aged 6 to 18 years. The authors identified children with ≥1 clonidine prescription; the authors examined their ICD-9...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics